The USA's BARDA has announced up to $500 million in Project NextGen funding to plan and execute multiple Phase IIb clinical ...

The Biomedical Advanced Research and Development Authority (BARDA) has selected Allucent as part of a five-year agreement in ...

The contract comes as researchers try to find more ways to broaden clinical trials to reach a wider demographic.

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a $749,999 contract to Cambridge, ...

The collaboration will develop therapeutics against influenza with a focus on RNA-mediated interference technologies.

Contract research organization Allucent has been chosen as a partner for the U.S. Biomedical Advanced Research and ...

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine GlobeNewswire July 15, 2024 Sudan ...

Project NextGen plans to support trials assessing the safety, efficacy, and immunogenicity of experimental Covid-19 vaccines.

A raw milk dairy farmer and longtime critic of the FDA has accused officials of ignoring his tip about a possible H5N1 ...

NEW YORK, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Gritstone bio, ...

The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55 million for rapid development of VIR-2482, the Vir ...

Ahead of next week's European Parliament plenary session in Strasbourg, German Conservative MEP Peter Liese (CDU, EPP) ...